Liver failure and sepsis gene study
Treatments studied
Part of Digestive system, Infections clinical trials.
This study analyzes gene activity in patients with severe liver failure or sepsis to understand why some recover and others don't. It may lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 years or older.
- You must be in the intensive care unit (ICU) for liver failure caused by taking too much acetaminophen (paracetamol).
- OR you must be in the ICU for severe infection (sepsis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with chronic liver disease who develop a serious infection called sepsis. The goal is to learn more about how to better treat or manage this condition.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This trial looks at children with sudden severe liver injury. It tests treatments for acute liver failure to understand how to help them recover.
This study looks at people with acute liver failure—a serious condition where the liver suddenly stops working—to understand what causes it and predict how patients will do. Researchers collect information about patients' health to identify patterns that might help doctors treat future patients better.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This study looks at how bacteria in your gut and other signs in your body affect liver and kidney damage in people with sepsis. It also compares findings to healthy volunteers to see what is different.
Hear when a new Acute Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.